ORCL deepens Bloom Energy tie-up with a 2.8 GW deal to fast-track AI data centers, but massive spending and execution risks raise questions for investors.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). REGENXBIO is a clinical-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that REGENXBIO, Inc.

Competition clearance marks next step in building comprehensive digital financial services ecosystem, accelerating digital financial services in Pakistan

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Applied Digital relies on a small customer base, fueling strong growth, but heavy dependence on a key client clouds long-term visibility.

TSN and HRL navigate a dynamic meat market, leveraging scale, branding and portfolio strategies to drive growth.

DIS' sports unit faces rising rights costs and margin pressure, as ESPN investments outpace revenue growth despite steady demand for live sports.

+4.0% on headline PPI year over year is a big jump of +60 bps month over month on final demand.

New York, New York--(Newsfile Corp. - April 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Concorde International Group Ltd. (NASDAQ: CIGL) between April 21, 2025 and July 14, 2025, inclusive (the "Class Period"), of the important May 20, 2026 lead plaintiff deadline.

As the Q1 2026 earnings season plays out, the focus is shifting from short-term performance to long-term income potential, with investors zeroing in on companies that continue to reward shareholders consistently through dividends.

Peace talks between the U.S. and Iran collapsed in Islamabad on April 11, 2026, and President Trump ordered the U.S.

Investing in index funds and ETFs that track broad market indexes is a sound strategy for most investors seeking diversified exposure without picking individual stocks.

Flareon leads the first wave of rotating releases, inviting fans to build their collection throughout the year ST. LOUIS, April 14, 2026 /PRNewswire/ -- Build-A-Bear Workshop® announces the launch of its Eevee Evolution campaign, transforming its Pokémon launch into an ongoing plush search inspired by the excitement of discovery.

Hewlett Packard Enterprise is initiated at a buy rating, driven by their AI infrastructure positioning and a deep value forward P/E near 10. Juniper Networks acquisition fueled Q1 headline growth, but organic expansion remains modest; record AI backlog signals robust demand despite supply constraints. Guidance calls for 5–10% normalized revenue growth and 32–40% non-GAAP operating profit growth, with margin expansion expected as Juniper synergies materialize.

PG's Beauty unit shines with 4% growth from premium innovation, while Baby Care lags due to inventory headwinds, with improvement eyed in the second half.

SYK to acquire Amplitude Vascular Systems, adding next-gen IVL tech to boost its peripheral vascular portfolio and expand arterial disease treatment reach.

Quantum computing stocks are surging in midday trading on Tuesday, with the sector's three most-watched pure-plays all posting double-digit gains.

PepsiCo (NASDAQ:PEP | PEP Price Prediction) trades at $156.20 as of writing and our price target for the stock is $177.14, implying upside of 13.41% over the next 12 months.

Cincinnati Financial's Commercial Lines Insurance business boosts growth, driven by a higher level of insured exposures, use of predictive analytics and agency appointments.

FB Financial Corporation (FBK) Q1 2026 Earnings Call Transcript